HER2-positive breast cancer is a fast-growing form of breast cancer driven by too much of a protein called HER2, but advances in treatment have transformed it from one of the most feared diagnoses to one with encouraging survival rates when caught early.

When a person receives a diagnosis of HER2-positive breast cancer, it means that laboratory tests have found unusually high levels of a specific protein on the surface of their breast cancer cells. This protein is called human epidermal growth factor receptor 2, or HER2 for short. The HER2 protein normally helps breast cells grow and repair themselves in a controlled way. However, when the gene responsible for making this protein malfunctions and creates too many copies of itself, the result is an overabundance of HER2 proteins that act like too many antennae receiving growth signals at once. This causes breast cells to divide and multiply far too quickly, leading to the formation of cancerous tumors that can be aggressive and fast-growing.^[1][2]

In healthy breast cells, the HER2 protein sits on the cell surface and receives signals that tell the cell when to grow, divide, and replace damaged or dying cells. This is a normal and essential process that keeps breast tissue healthy. But when something goes wrong with the HER2 gene, it can start producing far more copies of itself than needed. More gene copies mean more HER2 proteins are made, and these extra proteins send constant growth signals to breast cells. The cells respond by growing and dividing without the usual controls that would normally stop them, and this uncontrolled growth is what creates cancerous tumors.^[2][4]

The discovery of HER2-positive breast cancer happened in the 1980s when researchers were searching for genes that could cause cancer. Scientists knew that cancer resulted from normal cells growing unchecked, and they suspected specific genes or gene mutations enabled this to occur. When they identified a link between the HER2 gene and cancer formation, they demonstrated that a mutation in the HER2 gene stimulated cells to grow and divide excessively. Two independent research teams showed that the HER2 gene and its protein product could cause normal cells to grow uncontrollably like cancer cells.^[7]

Epidemiology

HER2-positive breast cancer represents a significant portion of all breast cancer cases diagnosed each year. Between 15 and 20 percent of invasive breast cancers are HER2-positive, meaning that approximately one in five women with breast cancer will have this particular subtype.^[2][3] When the HER2 gene was first linked to breast cancer, researchers estimated that the HER2 protein was overexpressed in 25 to 30 percent of breast cancers, though current testing methods have refined this estimate to the 15 to 20 percent range.^[7][8]

In terms of the broader picture, invasive breast cancers affect more than 290,000 women in the United States each year. Invasive breast cancers include invasive ductal carcinoma, which starts in the milk ducts and spreads to surrounding breast tissue, and lobular breast cancer, which begins in the milk-producing glands. Of these invasive breast cancer cases, between 15 and 20 percent will be HER2-positive.^[2]

It is important to note that HER2-positive breast cancer is far more common in women than in men. Men rarely develop HER2-positive breast cancer, making it predominantly a disease affecting women.^[2][13] About 10 to 20 percent of newly diagnosed breast cancers are HER2-positive, and when a tumor overexpresses or has too many HER2 proteins, it encourages the cancer cells to grow and divide more quickly, making the cancer more aggressive than some other types.^[5]

Causes

HER2-positive breast cancer occurs when the HER2 gene undergoes a mutation, or change, that causes it to malfunction. The HER2 gene is located on chromosome 17 in the body, and it contains the instructions for making the HER2 protein.^[8] When this gene works normally, it produces the right amount of HER2 protein to help breast cells grow, divide, and repair themselves in an orderly fashion. However, when the gene mutates, it can start making too many copies of itself through a process called gene amplification.^[4][8]

Gene amplification means that the HER2 gene duplicates itself multiple times, creating extra copies. Each of these extra gene copies produces HER2 proteins, leading to what doctors call overexpression of the HER2 protein. These excess proteins sit on the surface of breast cells like too many receivers picking up signals. Normally, HER2 proteins receive signals that tell cells to grow and divide as needed to replace damaged or dying cells. But when there are too many HER2 proteins, they pick up too many growth signals, causing breast cells to divide and grow uncontrollably. This uncontrolled growth leads to the formation of cancerous tumors.^[2][4]

The HER2 gene amplification is the primary pathway that leads to HER2 receptor overexpression and is a major driver of tumor development and progression in a subset of breast cancers.^[8] The mutation in the HER2 gene stimulates cells to grow and divide excessively, which is why HER2-positive breast cancer tends to be more aggressive and fast-growing than some other types of breast cancer.^[7]

Risk Factors

The risk factors for HER2-positive breast cancer are generally the same as those for breast cancer in general. Many different factors may increase a person’s risk of developing breast cancer, though it is important to understand that having one or more risk factors does not mean someone will definitely develop breast cancer. Likewise, some people develop breast cancer even when they have none of the known risk factors.^[2][13]

One significant risk factor is having an inherited genetic mutation, particularly in genes called BRCA1 or BRCA2. These gene mutations can be passed down through families and increase the likelihood of developing breast cancer. Another risk factor is having a personal history of breast cancer, meaning someone who has already had breast cancer once is at higher risk of developing it again.^[2][13]

Certain breast conditions can also increase risk. For example, having a condition called atypical ductal hyperplasia, which involves abnormal cells in the breast ducts, can raise the risk of breast cancer. Hormonal factors play a role as well. Starting menstrual periods earlier than usual or starting menopause later than usual exposes the body to hormones for a longer period, which can increase breast cancer risk. Taking hormone replacement therapy, which is sometimes used to manage menopause symptoms, is another factor that may raise risk.^[2][13]

Lifestyle factors matter too. Consuming more than one alcoholic drink per day has been linked to increased breast cancer risk. A history of radiation therapy, particularly radiation used to treat conditions such as certain types of lymphoma, can also increase the likelihood of developing breast cancer later in life.^[2][13]

Symptoms

Many people with HER2-positive breast cancer may not experience obvious symptoms at first, which is one reason why regular screening and awareness of breast changes are so important. When symptoms do appear, they are typically the same as those seen in other types of breast cancer. HER2-positive breast cancer does not have unique symptoms that distinguish it from other breast cancer subtypes.^[2][13]

One of the most common signs is a change in the size, shape, or contour of the breast. This might mean the breast looks different than it used to, or one breast looks different from the other. Another frequent symptom is finding a lump or mass in the breast, which may feel as small as a pea or could be larger. This lump or thickening might be felt in the breast itself or in the underarm area, and it typically persists through the menstrual cycle rather than coming and going.^[2][13]

Changes in the appearance or feel of the skin on the breast or nipple can also signal a problem. The skin might look dimpled or puckered, similar to the texture of an orange peel. It could appear scaly, inflamed, reddish, or darker than usual. Sometimes the skin might feel different, with a marble-like hardened area beneath the surface. Changes to the nipple itself can occur, including a discharge that is blood-stained or clear.^[2][13]

Prevention

While there is no guaranteed way to prevent HER2-positive breast cancer, certain lifestyle changes and preventive measures may help reduce overall breast cancer risk. Maintaining a healthy weight throughout life is one important factor, as studies have shown that obesity and significant weight gain are linked to increased breast cancer risk and poorer outcomes for those diagnosed with the disease.^[2]

Regular screening and early detection are critical components of prevention strategy, even though they do not prevent cancer from developing. Mammograms and other screening tests can find breast cancer early when it is most treatable. Early detection means treatment can begin sooner, which often leads to better outcomes and a higher chance of successful treatment.^[5]

For women with a strong family history of breast cancer or known genetic mutations like BRCA1 or BRCA2, genetic counseling and testing may be appropriate. Knowing about genetic risk factors allows women to work with their healthcare providers to develop personalized screening and prevention plans, which might include more frequent monitoring or even preventive measures in some cases.^[2]

Lifestyle choices that support general health may also play a role in reducing breast cancer risk. These include limiting alcohol consumption to no more than one drink per day, maintaining regular physical activity, and avoiding unnecessary exposure to radiation. For women considering hormone replacement therapy for menopause symptoms, it is important to discuss the potential risks and benefits with a healthcare provider, as hormone therapy may increase breast cancer risk.^[2]

Pathophysiology

Understanding how HER2-positive breast cancer develops at the cellular level helps explain why this type of cancer behaves the way it does and why certain treatments are effective. The pathophysiology of HER2-positive breast cancer centers on what happens when the HER2 gene and protein stop working normally and begin driving uncontrolled cell growth.

In normal, healthy breast tissue, the HER2 gene produces instructions for making the HER2 protein. This protein is a receptor that sits on the outer surface of breast cells, acting like an antenna or ear that receives signals from outside the cell. When the HER2 receptor receives the right signals, it tells the cell to grow, divide, and carry out other essential cellular processes. This is a carefully controlled system that ensures breast cells grow and divide only when needed to replace old or damaged cells.^[3][4]

In HER2-positive breast cancer, the HER2 gene undergoes amplification, creating multiple extra copies of itself. Each copy of the gene produces HER2 proteins, resulting in an overabundance of HER2 receptors on the cell surface. With so many receptors present, breast cells receive far too many growth signals. The cells respond by growing and dividing much faster than they should, without the normal controls that would stop this process. This excessive, uncontrolled growth is what creates tumors.^[2][4]

The HER2 receptor is part of a family of proteins called tyrosine kinases, which are membrane receptors that, when activated, affect cell proliferation and survival. In breast cancer, the overexpressed HER2 receptor becomes a major driver of tumor development and progression. Because these cancer cells are so responsive to growth signals, HER2-positive breast cancers tend to grow faster and are more likely to spread to other parts of the body compared to some other types of breast cancer.^[8]

The good news is that the overabundance of HER2 proteins on cancer cells makes them an excellent target for treatment. Medicines specifically designed to attach to HER2 receptors can block them from receiving growth signals, effectively slowing or stopping the cancer’s growth. This is why HER2-positive breast cancer, once considered one of the most aggressive and difficult-to-treat forms, now has much better outcomes thanks to targeted therapies that exploit this biological vulnerability.^[1][4]

About half of people with HER2-positive breast cancer are diagnosed after the cancer has already spread to other areas of the body, a situation called metastatic or stage 4 cancer. One particularly concerning complication is that up to 50 percent of metastatic HER2-positive cases can develop brain metastasis, where cancer cells spread to the brain. This can be life-threatening and requires specialized treatment approaches.^[2][5]

However, when HER2-positive breast cancer is diagnosed before it spreads, healthcare providers can successfully treat and often cure it. The prognosis for HER2-positive breast cancer has dramatically improved over the past few decades. What was once a diagnosis that doctors dreaded giving has become one where people with HER2-positive disease actually generally do better than people with other types of breast cancer because of new therapies that specifically target the HER2 protein.^[2][5]